Download presentation
Presentation is loading. Please wait.
1
Anaerobic bacteria Norazli Ghadin
2
Learning objectives Able to describe basic characteristic of anaerobic bacteria Able to discuss oxygen toxicity, ROS formation during respiration and enzyme involve in eliminating ROS Able to discuss the virulence factor of anaerobic bacteria Able to describe the clinical manifestation of anaerobic bacteria infection. Able to correlate important anaerobic bacteria with human health Clostridium sp. others
3
What Are Anaerobic Microorganisms
Anaerobic microorganisms are widespread and very important Do not require oxygen for growth - often extremely toxic
4
Defining Anaerobes Facultative anaerobes - can grow in the presence or absence of oxygen Obtain energy by both respiration and fermentation Oxygen not toxic, some use nitrate (NO3-) or sulphate (SO42-) as a terminal electron acceptor under anaerobic conditions
5
Strict Anaerobic Bacteria
Obligate (strict) anaerobes - oxygen is toxic to these organisms, do not use oxygen as terminal electron acceptor. Archaea such as methanogens and Bacteria, e.g Clostridia, Bacteriodes etc. etc.
6
The Requirements for Growth: Related to Oxygen
Oxygen (O2) Table 6.1
7
Anaerobes and Oxygen Anaerobes generate energy by fermentation
Lack the capacity to utilize O2 as a terminal hydrogen acceptor Some are sensitive to O2 concentration as low as 0.5% O2 Most can survive in 3%-5% O2 A few can grow poorly in the presence of air aero tolerant anaerobes Many are members of the normal flora created by presence of facultative anaerobes
8
Oxygen Toxicity Oxygen is used by aerobic and facultatively anaerobic organisms as its strong oxidising ability makes it an excellent electron acceptor During the stepwise reduction of oxygen, which takes place in respiration toxic and highly reactive intermediates are produced reactive oxygen species (ROS).
9
ROS production during respiration
O2 + e- => O superoxide anion O2- + e- + 2H+ => H2O hydrogen peroxide H2O2 + e- + H+ => H2O + OH Hydroxyl radical OH. + e- + H+ => H2O water
10
Chemical Dynamics in Anaerobic Bacteria
Organisms that use O2 have developed defence mechanisms to protect themselves from these toxic forms of oxygen - enzymes Catalase: H2O2 + H2O2 => 2H2O + O2 Peroxidase: H2O2 + NADH + H+ => 2H2O NAD+ Superoxide dismutase: O2- + O2- + 2H+ => H2O O2
11
Anaerobic environments exist in Nature too
Anaerobic environments (low reduction potential) include: Sediments of lakes, rivers and oceans; bogs, marshes, flooded soils, intestinal tract of animals; oral cavity of animals, deep underground areas, e.g. oil packets and some aquifers Anaerobes also important in some infections, e.g. C. tetanii and C. perfringens important in deep puncture wound infections Dr.T.V.Rao MD
12
Anaerobic Environments
13
FACTORS THAT INHIBIT THE GROWTH OF ANAEROBES BY OXYGEN
1. Toxic compounds are produced e.g. H2O2 , Superoxide's 2. Absence of catalase & Superoxide dismutase 3. Oxidation of essential sulfhydryl groups in enzymes without sufficient reducing power to regenerate them
14
ANAEROBES OF CLINICAL IMPORTANCE
CLOSTRIDIA C tetani; C perfringens; C difficile; C botulinum BACTEROIDES B fragilis; Prevotella Porphyromonas ACTINOMYCES FUSOBACTERIUM ANAEROBIC STREPTOCOCCI
15
Sites and Infection produced by Anaerobes
17
Anaerobic Bacteria of Medical Interest
MORPHOLOGY GRAM STAIN GENUS Spore forming (+) Clostridium Non-spore forming bacilli (-) Actinomycetes, Bifidobacterium,Eubacte-rium,Propionibacerium, Mobilncus,Lactobacillus Bacteroides,Fusobacterium Prevotella,Porphyromonas Non-sporefoming cocci Peptococcus, Pepto-streptococcus Streptococcus Veilonella
18
Gram-positive anaerobes
Actinomyces (head, neck, pelvic infections; aspiration pneumonia) Bifid bacterium (ear infections, abdominal infections) Clostridium (gas, gangrene, food poisoning, tetanus, pseudomembranous colitis) Peptostreptococcus (oral, respiratory, and intra- abdominal infections) Propionibacterium (shunt infections)
19
Gram-negative anaerobes
Bactericides (the most commonly found anaerobes in cultures; intra-abdominal infections, rectal abscesses, soft tissue infections, liver infection) Fusobacterium (abscesses, wound infections, pulmonary and intracranial infections) Porphyromonas (aspiration pneumonia, periodontitis) Prevotella (intra-abdominal infections, soft tissue infections)
20
ANAEROBIC GRAM NEGATIVE BACILLI
Bactericides, Prevotolla, Porphyromonas and Fusobacterium Present in GI tract -form large component of normal flora >80% of human infections associated with B fragilis virulence factors - capsule, LPS, agglutinins and enzymes Clinical - Endogenous infections Intra-abdominal pyogenic infections pleuro-pulmonary infections genital infection
21
FACTORS RESPONSIBLE FOR THEIR VIRULENCE
1. Lipopolysaccharide - promotes abscess formation, enhanced coagulation 2. Polysaccharide capsule - correlated with abscess production 3. Enzymes a. Collagenase b. Heparinase * develop thrombophlebitis & septic emboli 4. Short chained fatty acids a. Butyrate- seen in dental plaque b. succinic acid – reduces phagocytic killing Dr.T.V.Rao MD
22
CLINICAL MANIFESTATION
Clinical hints 1. odor 2. tissue 3. location 4. necrotic tissue 5. endocarditis with (-) blood culture 6. infection associated with malignancy 7. black discoloration 8. blood containing exudates 9. associated with sulfur granules 10. Bacteremic feature with jaundice 11. human bites
23
Common Human Anaerobic Infections
24
CLOSTRIDIA Gram positive spore forming bacilli ubiquitous
intestines of man and animals animal and human faeces contaminated soil and water Several species associated with human disease
25
Clostridium perfringens
Large rectangular Gram positive bacillus Spores seldom seen in vivo or in vitro non motile Produces several toxins alpha (lecithinase), beta, epsilon enterotoxin Causes a spectrum of human diseases Bacteraemia Myonecrosis food poisoning enteritis necrotica (pig bel) Dr.T.V.Rao MD
26
Clostridium tetani Small motile spore forming gram positive bacillus with round terminal spores Causes tetanus Pathogenesis: produces tetanospasmin during stationary phase which is released when cell lysis occurs heavy chain binds to ganglioside on neuronal membranes toxin internalized and moves from peripheral to central nervous system by retrograde axonal transport crosses synapse and localized within vesicles acts by blocking release of inhibitory neurotransmitters (eg GABA)
27
Clostridium difficile
Associated with human disease in mid-1970’s Found in human GIT in small numbers With antibiotic use, increase in number in GIT Clindamycin, ampicillin, cephalosporins Produces 2 entero toxins Toxin A -enterotoxin & Toxin B -cytotoxin Diagnosis Detection of toxins in stools, culture of organism Clinical - AAC Pseudomembranous colitis Treatment omit antibiotic if possible oral vancomycin (125mg qds or metronidazole
28
Clostridium botulinum
Fastidious spore forming anaerobic gram positive bacillus Produces 8 antigenically distinct toxins Human disease described with types A, B & E Heavy chain binds to ganglioside receptor Toxin internalized and prevents release of acetyl choline from vesicles Clinical Food borne botulism (weakness, dizziness, ocular palsy and progressive flaccid paralysis) infant botulism (floppy baby) wound botulism
29
ANAEROBIC GRAM NEGATIVE BACILLI
Bactericides, Prevotolla, Porphyromonas and Fusobacterium Present in GI tract -form large component of normal flora >80% of human infections associated with B fragilis virulence factors - capsule, LPS, agglutinins and enzymes Clinical - Endogenous infections Intra-abdominal pyogenic infections pleuro-pulmonary infections genital infection
30
ACTINOMYCES Strict anaerobic Gram positive bacilli typically arranged in hyphae which fragment into short bacilli Normal flora of upper respiratory tract, GI tract and female genital tract. Low virulence produce disease when mucosal barrier is breached (eg: following dental trauma or surgery) ENDOGENOUS Establishes chronic infection that spreads through normal anatomical barriers Clinical -cervicofacial, abdominal and thoracic Diagnosis: Gram stain of ‘sulpher’ granules culture
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.